nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—endogenous depression—Amitriptyline—migraine	0.177	0.54	CpDpCtD
Nefazodone—endogenous depression—Valproic Acid—migraine	0.151	0.46	CpDpCtD
Nefazodone—HTR2C—migraine	0.0823	0.291	CbGaD
Nefazodone—HTR1A—migraine	0.0799	0.283	CbGaD
Nefazodone—SLC6A4—migraine	0.0682	0.241	CbGaD
Nefazodone—HTR2A—migraine	0.0524	0.185	CbGaD
Nefazodone—SLC6A4—Amitriptyline—migraine	0.0166	0.0668	CbGbCtD
Nefazodone—ADRA1B—Amitriptyline—migraine	0.0152	0.0612	CbGbCtD
Nefazodone—HTR1A—Propranolol—migraine	0.0151	0.0609	CbGbCtD
Nefazodone—SLC6A2—Amitriptyline—migraine	0.0139	0.0559	CbGbCtD
Nefazodone—HTR2C—Amitriptyline—migraine	0.0139	0.0559	CbGbCtD
Nefazodone—SLC6A4—Verapamil—migraine	0.0132	0.053	CbGbCtD
Nefazodone—HTR1A—Amitriptyline—migraine	0.0131	0.0527	CbGbCtD
Nefazodone—HTR2A—Amitriptyline—migraine	0.0125	0.0504	CbGbCtD
Nefazodone—ADRA2A—Amitriptyline—migraine	0.0125	0.0504	CbGbCtD
Nefazodone—ADRA1A—Amitriptyline—migraine	0.012	0.0483	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Propranolol—migraine	0.0105	0.0421	CbGbCtD
Nefazodone—CYP3A7—Propranolol—migraine	0.0105	0.0421	CbGbCtD
Nefazodone—CYP3A5—Propranolol—migraine	0.00785	0.0316	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Verapamil—migraine	0.00718	0.0289	CbGbCtD
Nefazodone—CYP3A7—Verapamil—migraine	0.00718	0.0289	CbGbCtD
Nefazodone—CYP3A5—Amitriptyline—migraine	0.00679	0.0273	CbGbCtD
Nefazodone—CYP3A5—Valproic Acid—migraine	0.00619	0.0249	CbGbCtD
Nefazodone—ABCB1—Timolol—migraine	0.00573	0.0231	CbGbCtD
Nefazodone—CYP2D6—Timolol—migraine	0.0054	0.0217	CbGbCtD
Nefazodone—CYP3A5—Verapamil—migraine	0.00539	0.0217	CbGbCtD
Nefazodone—ABCB1—Propranolol—migraine	0.00511	0.0206	CbGbCtD
Nefazodone—CYP2D6—Propranolol—migraine	0.00481	0.0194	CbGbCtD
Nefazodone—ABCB1—Amitriptyline—migraine	0.00442	0.0178	CbGbCtD
Nefazodone—CYP2D6—Amitriptyline—migraine	0.00416	0.0168	CbGbCtD
Nefazodone—ABCB1—Verapamil—migraine	0.00351	0.0141	CbGbCtD
Nefazodone—CYP2D6—Verapamil—migraine	0.0033	0.0133	CbGbCtD
Nefazodone—CYP3A4—Propranolol—migraine	0.00306	0.0123	CbGbCtD
Nefazodone—HTR2A—trigeminal nucleus—migraine	0.00303	0.142	CbGeAlD
Nefazodone—CYP3A4—Amitriptyline—migraine	0.00265	0.0107	CbGbCtD
Nefazodone—CYP3A4—Valproic Acid—migraine	0.00241	0.00972	CbGbCtD
Nefazodone—CYP3A4—Topiramate—migraine	0.00218	0.00877	CbGbCtD
Nefazodone—CYP3A4—Verapamil—migraine	0.0021	0.00846	CbGbCtD
Nefazodone—SLC6A2—locus ceruleus—migraine	0.00162	0.0756	CbGeAlD
Nefazodone—SLC6A2—sympathetic nervous system—migraine	0.00128	0.0598	CbGeAlD
Nefazodone—HTR2A—locus ceruleus—migraine	0.000973	0.0454	CbGeAlD
Nefazodone—SLC6A2—autonomic nervous system—migraine	0.00086	0.0402	CbGeAlD
Nefazodone—HTR2A—trigeminal nerve—migraine	0.000797	0.0372	CbGeAlD
Nefazodone—HTR2A—sympathetic nervous system—migraine	0.000769	0.0359	CbGeAlD
Nefazodone—SLC6A3—nerve—migraine	0.0006	0.028	CbGeAlD
Nefazodone—HTR2A—cranial nerve—migraine	0.000568	0.0265	CbGeAlD
Nefazodone—HTR2A—pons—migraine	0.000561	0.0262	CbGeAlD
Nefazodone—HTR2A—autonomic nervous system—migraine	0.000517	0.0241	CbGeAlD
Nefazodone—SLC6A2—nerve—migraine	0.000484	0.0226	CbGeAlD
Nefazodone—ADRA2A—peripheral nervous system—migraine	0.000439	0.0205	CbGeAlD
Nefazodone—HTR2A—pineal body—migraine	0.0004	0.0187	CbGeAlD
Nefazodone—HTR2A—peripheral nervous system—migraine	0.000373	0.0174	CbGeAlD
Nefazodone—HTR2A—nerve—migraine	0.000291	0.0136	CbGeAlD
Nefazodone—SLC6A3—brainstem—migraine	0.000258	0.012	CbGeAlD
Nefazodone—HTR2C—brainstem—migraine	0.000249	0.0116	CbGeAlD
Nefazodone—SLC6A4—brainstem—migraine	0.000236	0.011	CbGeAlD
Nefazodone—HTR2A—blood vessel—migraine	0.000228	0.0107	CbGeAlD
Nefazodone—HTR1A—brainstem—migraine	0.00021	0.00978	CbGeAlD
Nefazodone—SLC6A2—brainstem—migraine	0.000208	0.0097	CbGeAlD
Nefazodone—ADRA1A—brainstem—migraine	0.000193	0.00902	CbGeAlD
Nefazodone—ADRA1B—head—migraine	0.00019	0.00887	CbGeAlD
Nefazodone—ADRA1B—nervous system—migraine	0.00018	0.00841	CbGeAlD
Nefazodone—ADRA1B—central nervous system—migraine	0.000173	0.0081	CbGeAlD
Nefazodone—Aripiprazole—HTR3A—migraine	0.000171	0.0639	CrCbGaD
Nefazodone—HTR1A—cardiovascular system—migraine	0.000171	0.00798	CbGeAlD
Nefazodone—Aripiprazole—HTR1D—migraine	0.000169	0.0632	CrCbGaD
Nefazodone—Aripiprazole—HTR2B—migraine	0.000167	0.0625	CrCbGaD
Nefazodone—Trazodone—HTR2B—migraine	0.000167	0.0622	CrCbGaD
Nefazodone—ADRA2A—trigeminal ganglion—migraine	0.000166	0.00775	CbGeAlD
Nefazodone—HTR2A—neck—migraine	0.000163	0.00763	CbGeAlD
Nefazodone—ADRA1A—cardiovascular system—migraine	0.000158	0.00736	CbGeAlD
Nefazodone—ABCB1—blood vessel—migraine	0.00015	0.00699	CbGeAlD
Nefazodone—SLC6A3—head—migraine	0.000142	0.00664	CbGeAlD
Nefazodone—ADRA1B—brain—migraine	0.000138	0.00643	CbGeAlD
Nefazodone—HTR2C—head—migraine	0.000138	0.00642	CbGeAlD
Nefazodone—SLC6A3—nervous system—migraine	0.000135	0.0063	CbGeAlD
Nefazodone—HTR2C—nervous system—migraine	0.00013	0.00609	CbGeAlD
Nefazodone—SLC6A4—head—migraine	0.00013	0.00609	CbGeAlD
Nefazodone—SLC6A3—central nervous system—migraine	0.00013	0.00607	CbGeAlD
Nefazodone—SLC6A3—cerebellum—migraine	0.000127	0.00593	CbGeAlD
Nefazodone—HTR2C—central nervous system—migraine	0.000126	0.00586	CbGeAlD
Nefazodone—HTR2A—brainstem—migraine	0.000125	0.00583	CbGeAlD
Nefazodone—SLC6A4—nervous system—migraine	0.000124	0.00577	CbGeAlD
Nefazodone—SLC6A4—central nervous system—migraine	0.000119	0.00556	CbGeAlD
Nefazodone—HTR1A—head—migraine	0.000116	0.00541	CbGeAlD
Nefazodone—SLC6A2—head—migraine	0.000115	0.00536	CbGeAlD
Nefazodone—CYP2D6—brainstem—migraine	0.000114	0.00531	CbGeAlD
Nefazodone—HTR1A—nervous system—migraine	0.00011	0.00513	CbGeAlD
Nefazodone—SLC6A2—nervous system—migraine	0.000109	0.00508	CbGeAlD
Nefazodone—Quetiapine—HTR3A—migraine	0.000107	0.0399	CrCbGaD
Nefazodone—ADRA1A—head—migraine	0.000107	0.00498	CbGeAlD
Nefazodone—Quetiapine—HTR1D—migraine	0.000106	0.0395	CrCbGaD
Nefazodone—HTR1A—central nervous system—migraine	0.000106	0.00494	CbGeAlD
Nefazodone—SLC6A2—central nervous system—migraine	0.000105	0.00489	CbGeAlD
Nefazodone—Aripiprazole—HTR7—migraine	0.000104	0.0387	CrCbGaD
Nefazodone—HTR1A—cerebellum—migraine	0.000103	0.00482	CbGeAlD
Nefazodone—SLC6A3—brain—migraine	0.000103	0.00482	CbGeAlD
Nefazodone—HTR2A—cardiovascular system—migraine	0.000102	0.00476	CbGeAlD
Nefazodone—ADRA1A—nervous system—migraine	0.000101	0.00473	CbGeAlD
Nefazodone—Aripiprazole—HTR1B—migraine	0.0001	0.0375	CrCbGaD
Nefazodone—HTR2C—brain—migraine	9.97e-05	0.00465	CbGeAlD
Nefazodone—ADRA1A—central nervous system—migraine	9.74e-05	0.00455	CbGeAlD
Nefazodone—ADRA1A—cerebellum—migraine	9.52e-05	0.00445	CbGeAlD
Nefazodone—SLC6A4—brain—migraine	9.45e-05	0.00441	CbGeAlD
Nefazodone—ABCB1—trigeminal ganglion—migraine	9.25e-05	0.00432	CbGeAlD
Nefazodone—HTR1A—brain—migraine	8.39e-05	0.00392	CbGeAlD
Nefazodone—SLC6A2—brain—migraine	8.32e-05	0.00388	CbGeAlD
Nefazodone—Aripiprazole—HTR2C—migraine	8.18e-05	0.0305	CrCbGaD
Nefazodone—Trazodone—HTR2C—migraine	8.14e-05	0.0304	CrCbGaD
Nefazodone—ADRA2A—head—migraine	8.12e-05	0.00379	CbGeAlD
Nefazodone—Aripiprazole—HTR1A—migraine	7.94e-05	0.0297	CrCbGaD
Nefazodone—Trazodone—HTR1A—migraine	7.91e-05	0.0295	CrCbGaD
Nefazodone—ADRA1A—brain—migraine	7.74e-05	0.00361	CbGeAlD
Nefazodone—ADRA2A—nervous system—migraine	7.69e-05	0.00359	CbGeAlD
Nefazodone—Thioproperazine—HTR1A—migraine	7.53e-05	0.0281	CrCbGaD
Nefazodone—ADRA2A—central nervous system—migraine	7.41e-05	0.00346	CbGeAlD
Nefazodone—Prochlorperazine—HTR2C—migraine	7.29e-05	0.0272	CrCbGaD
Nefazodone—ADRA2A—cerebellum—migraine	7.24e-05	0.00338	CbGeAlD
Nefazodone—HTR2A—head—migraine	6.9e-05	0.00322	CbGeAlD
Nefazodone—Aripiprazole—SLC6A4—migraine	6.78e-05	0.0253	CrCbGaD
Nefazodone—Trazodone—SLC6A4—migraine	6.75e-05	0.0252	CrCbGaD
Nefazodone—ABCB1—cardiovascular system—migraine	6.68e-05	0.00312	CbGeAlD
Nefazodone—Perphenazine—HTR7—migraine	6.61e-05	0.0247	CrCbGaD
Nefazodone—Fluphenazine—HTR2C—migraine	6.6e-05	0.0246	CrCbGaD
Nefazodone—HTR2A—nervous system—migraine	6.54e-05	0.00305	CbGeAlD
Nefazodone—Quetiapine—HTR7—migraine	6.48e-05	0.0242	CrCbGaD
Nefazodone—Fluphenazine—HTR1A—migraine	6.4e-05	0.0239	CrCbGaD
Nefazodone—HTR2A—central nervous system—migraine	6.3e-05	0.00294	CbGeAlD
Nefazodone—CYP2D6—head—migraine	6.29e-05	0.00294	CbGeAlD
Nefazodone—Quetiapine—HTR1B—migraine	6.27e-05	0.0234	CrCbGaD
Nefazodone—HTR2A—cerebellum—migraine	6.16e-05	0.00287	CbGeAlD
Nefazodone—CYP3A4—nervous system—migraine	6.06e-05	0.00283	CbGeAlD
Nefazodone—CYP2D6—nervous system—migraine	5.96e-05	0.00278	CbGeAlD
Nefazodone—ADRA2A—brain—migraine	5.88e-05	0.00275	CbGeAlD
Nefazodone—CYP3A4—central nervous system—migraine	5.83e-05	0.00272	CbGeAlD
Nefazodone—CYP2D6—central nervous system—migraine	5.74e-05	0.00268	CbGeAlD
Nefazodone—Erythema multiforme—Gabapentin—migraine	5.68e-05	0.000725	CcSEcCtD
Nefazodone—Vertigo—Valproic Acid—migraine	5.66e-05	0.000724	CcSEcCtD
Nefazodone—Asthenia—Propranolol—migraine	5.66e-05	0.000723	CcSEcCtD
Nefazodone—Pneumonia—Topiramate—migraine	5.66e-05	0.000723	CcSEcCtD
Nefazodone—Leukopenia—Valproic Acid—migraine	5.64e-05	0.000721	CcSEcCtD
Nefazodone—Zuclopenthixol—HTR2A—migraine	5.64e-05	0.021	CrCbGaD
Nefazodone—CYP2D6—cerebellum—migraine	5.61e-05	0.00262	CbGeAlD
Nefazodone—Tinnitus—Gabapentin—migraine	5.6e-05	0.000715	CcSEcCtD
Nefazodone—Stevens-Johnson syndrome—Topiramate—migraine	5.58e-05	0.000713	CcSEcCtD
Nefazodone—Palpitations—Valproic Acid—migraine	5.57e-05	0.000712	CcSEcCtD
Nefazodone—Cough—Valproic Acid—migraine	5.5e-05	0.000703	CcSEcCtD
Nefazodone—Dysgeusia—Timolol—migraine	5.5e-05	0.000702	CcSEcCtD
Nefazodone—Stomatitis—Topiramate—migraine	5.48e-05	0.000701	CcSEcCtD
Nefazodone—Conjunctivitis—Topiramate—migraine	5.47e-05	0.000699	CcSEcCtD
Nefazodone—Urinary tract infection—Topiramate—migraine	5.47e-05	0.000699	CcSEcCtD
Nefazodone—Hypertension—Valproic Acid—migraine	5.44e-05	0.000695	CcSEcCtD
Nefazodone—Diarrhoea—Propranolol—migraine	5.4e-05	0.000689	CcSEcCtD
Nefazodone—Chills—Gabapentin—migraine	5.39e-05	0.000688	CcSEcCtD
Nefazodone—Myalgia—Valproic Acid—migraine	5.37e-05	0.000686	CcSEcCtD
Nefazodone—Arthralgia—Valproic Acid—migraine	5.37e-05	0.000686	CcSEcCtD
Nefazodone—Chest pain—Valproic Acid—migraine	5.37e-05	0.000686	CcSEcCtD
Nefazodone—Haematuria—Topiramate—migraine	5.36e-05	0.000685	CcSEcCtD
Nefazodone—Anxiety—Valproic Acid—migraine	5.35e-05	0.000683	CcSEcCtD
Nefazodone—Hypersensitivity—Verapamil—migraine	5.35e-05	0.000683	CcSEcCtD
Nefazodone—Epistaxis—Topiramate—migraine	5.31e-05	0.000678	CcSEcCtD
Nefazodone—Alopecia—Gabapentin—migraine	5.3e-05	0.000678	CcSEcCtD
Nefazodone—Discomfort—Valproic Acid—migraine	5.3e-05	0.000677	CcSEcCtD
Nefazodone—Vision blurred—Timolol—migraine	5.29e-05	0.000676	CcSEcCtD
Nefazodone—Sinusitis—Topiramate—migraine	5.28e-05	0.000674	CcSEcCtD
Nefazodone—Trifluoperazine—HTR2C—migraine	5.27e-05	0.0197	CrCbGaD
Nefazodone—Dry mouth—Valproic Acid—migraine	5.25e-05	0.000671	CcSEcCtD
Nefazodone—Dizziness—Propranolol—migraine	5.22e-05	0.000666	CcSEcCtD
Nefazodone—Perphenazine—HTR2C—migraine	5.22e-05	0.0195	CrCbGaD
Nefazodone—Aripiprazole—HTR2A—migraine	5.21e-05	0.0195	CrCbGaD
Nefazodone—Asthenia—Verapamil—migraine	5.21e-05	0.000665	CcSEcCtD
Nefazodone—Confusional state—Valproic Acid—migraine	5.19e-05	0.000663	CcSEcCtD
Nefazodone—Trazodone—HTR2A—migraine	5.19e-05	0.0194	CrCbGaD
Nefazodone—Flatulence—Gabapentin—migraine	5.15e-05	0.000658	CcSEcCtD
Nefazodone—Anaphylactic shock—Valproic Acid—migraine	5.14e-05	0.000657	CcSEcCtD
Nefazodone—Oedema—Valproic Acid—migraine	5.14e-05	0.000657	CcSEcCtD
Nefazodone—Bradycardia—Topiramate—migraine	5.14e-05	0.000657	CcSEcCtD
Nefazodone—Pruritus—Verapamil—migraine	5.13e-05	0.000656	CcSEcCtD
Nefazodone—Angioedema—Timolol—migraine	5.13e-05	0.000655	CcSEcCtD
Nefazodone—Trifluoperazine—HTR1A—migraine	5.12e-05	0.0191	CrCbGaD
Nefazodone—Dysgeusia—Gabapentin—migraine	5.12e-05	0.000654	CcSEcCtD
Nefazodone—Quetiapine—HTR2C—migraine	5.11e-05	0.0191	CrCbGaD
Nefazodone—Infection—Valproic Acid—migraine	5.11e-05	0.000653	CcSEcCtD
Nefazodone—Haemoglobin—Topiramate—migraine	5.08e-05	0.000648	CcSEcCtD
Nefazodone—Perphenazine—HTR1A—migraine	5.06e-05	0.0189	CrCbGaD
Nefazodone—Rhinitis—Topiramate—migraine	5.06e-05	0.000647	CcSEcCtD
Nefazodone—Back pain—Gabapentin—migraine	5.05e-05	0.000646	CcSEcCtD
Nefazodone—Haemorrhage—Topiramate—migraine	5.05e-05	0.000645	CcSEcCtD
Nefazodone—Hepatitis—Topiramate—migraine	5.05e-05	0.000645	CcSEcCtD
Nefazodone—Vertigo—Timolol—migraine	5.04e-05	0.000644	CcSEcCtD
Nefazodone—Thrombocytopenia—Valproic Acid—migraine	5.04e-05	0.000644	CcSEcCtD
Nefazodone—Syncope—Timolol—migraine	5.03e-05	0.000643	CcSEcCtD
Nefazodone—Hypoaesthesia—Topiramate—migraine	5.02e-05	0.000642	CcSEcCtD
Nefazodone—Hallucination—Topiramate—migraine	5.02e-05	0.000642	CcSEcCtD
Nefazodone—Muscle spasms—Gabapentin—migraine	5.02e-05	0.000642	CcSEcCtD
Nefazodone—Tachycardia—Valproic Acid—migraine	5.02e-05	0.000641	CcSEcCtD
Nefazodone—Vomiting—Propranolol—migraine	5.02e-05	0.000641	CcSEcCtD
Nefazodone—Pharyngitis—Topiramate—migraine	5.01e-05	0.00064	CcSEcCtD
Nefazodone—HTR2A—brain—migraine	5e-05	0.00233	CbGeAlD
Nefazodone—Oedema peripheral—Topiramate—migraine	4.98e-05	0.000636	CcSEcCtD
Nefazodone—Hyperhidrosis—Valproic Acid—migraine	4.97e-05	0.000635	CcSEcCtD
Nefazodone—Rash—Propranolol—migraine	4.97e-05	0.000635	CcSEcCtD
Nefazodone—Dermatitis—Propranolol—migraine	4.97e-05	0.000635	CcSEcCtD
Nefazodone—Quetiapine—HTR1A—migraine	4.96e-05	0.0185	CrCbGaD
Nefazodone—Diarrhoea—Verapamil—migraine	4.96e-05	0.000634	CcSEcCtD
Nefazodone—Palpitations—Timolol—migraine	4.96e-05	0.000634	CcSEcCtD
Nefazodone—Thioproperazine—HTR2A—migraine	4.94e-05	0.0184	CrCbGaD
Nefazodone—Loss of consciousness—Timolol—migraine	4.93e-05	0.00063	CcSEcCtD
Nefazodone—Vision blurred—Gabapentin—migraine	4.92e-05	0.000629	CcSEcCtD
Nefazodone—Anorexia—Valproic Acid—migraine	4.9e-05	0.000626	CcSEcCtD
Nefazodone—Cough—Timolol—migraine	4.9e-05	0.000626	CcSEcCtD
Nefazodone—Tremor—Gabapentin—migraine	4.9e-05	0.000625	CcSEcCtD
Nefazodone—Visual impairment—Topiramate—migraine	4.87e-05	0.000622	CcSEcCtD
Nefazodone—Ill-defined disorder—Gabapentin—migraine	4.85e-05	0.000619	CcSEcCtD
Nefazodone—Hypertension—Timolol—migraine	4.84e-05	0.000619	CcSEcCtD
Nefazodone—Anaemia—Gabapentin—migraine	4.83e-05	0.000617	CcSEcCtD
Nefazodone—Hypotension—Valproic Acid—migraine	4.81e-05	0.000614	CcSEcCtD
Nefazodone—Agitation—Gabapentin—migraine	4.8e-05	0.000614	CcSEcCtD
Nefazodone—Dizziness—Verapamil—migraine	4.8e-05	0.000613	CcSEcCtD
Nefazodone—Arthralgia—Timolol—migraine	4.78e-05	0.00061	CcSEcCtD
Nefazodone—Chest pain—Timolol—migraine	4.78e-05	0.00061	CcSEcCtD
Nefazodone—Myalgia—Timolol—migraine	4.78e-05	0.00061	CcSEcCtD
Nefazodone—Erythema multiforme—Topiramate—migraine	4.78e-05	0.00061	CcSEcCtD
Nefazodone—Angioedema—Gabapentin—migraine	4.77e-05	0.00061	CcSEcCtD
Nefazodone—Anxiety—Timolol—migraine	4.76e-05	0.000608	CcSEcCtD
Nefazodone—Discomfort—Timolol—migraine	4.72e-05	0.000603	CcSEcCtD
Nefazodone—Malaise—Gabapentin—migraine	4.71e-05	0.000602	CcSEcCtD
Nefazodone—Tinnitus—Topiramate—migraine	4.71e-05	0.000602	CcSEcCtD
Nefazodone—Vertigo—Gabapentin—migraine	4.69e-05	0.0006	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Valproic Acid—migraine	4.69e-05	0.000599	CcSEcCtD
Nefazodone—Flushing—Topiramate—migraine	4.69e-05	0.000599	CcSEcCtD
Nefazodone—Syncope—Gabapentin—migraine	4.69e-05	0.000599	CcSEcCtD
Nefazodone—Nausea—Propranolol—migraine	4.69e-05	0.000599	CcSEcCtD
Nefazodone—Leukopenia—Gabapentin—migraine	4.68e-05	0.000598	CcSEcCtD
Nefazodone—Dry mouth—Timolol—migraine	4.67e-05	0.000597	CcSEcCtD
Nefazodone—Insomnia—Valproic Acid—migraine	4.65e-05	0.000594	CcSEcCtD
Nefazodone—Paraesthesia—Valproic Acid—migraine	4.62e-05	0.00059	CcSEcCtD
Nefazodone—Palpitations—Gabapentin—migraine	4.62e-05	0.00059	CcSEcCtD
Nefazodone—Confusional state—Timolol—migraine	4.62e-05	0.00059	CcSEcCtD
Nefazodone—Vomiting—Verapamil—migraine	4.61e-05	0.000589	CcSEcCtD
Nefazodone—Loss of consciousness—Gabapentin—migraine	4.59e-05	0.000587	CcSEcCtD
Nefazodone—Dyspnoea—Valproic Acid—migraine	4.59e-05	0.000586	CcSEcCtD
Nefazodone—Anaphylactic shock—Timolol—migraine	4.58e-05	0.000585	CcSEcCtD
Nefazodone—Oedema—Timolol—migraine	4.58e-05	0.000585	CcSEcCtD
Nefazodone—Rash—Verapamil—migraine	4.57e-05	0.000584	CcSEcCtD
Nefazodone—Somnolence—Valproic Acid—migraine	4.57e-05	0.000584	CcSEcCtD
Nefazodone—Dermatitis—Verapamil—migraine	4.57e-05	0.000584	CcSEcCtD
Nefazodone—Cough—Gabapentin—migraine	4.56e-05	0.000583	CcSEcCtD
Nefazodone—CYP2D6—brain—migraine	4.56e-05	0.00213	CbGeAlD
Nefazodone—Infection—Timolol—migraine	4.55e-05	0.000581	CcSEcCtD
Nefazodone—Headache—Verapamil—migraine	4.55e-05	0.000581	CcSEcCtD
Nefazodone—Chills—Topiramate—migraine	4.53e-05	0.000579	CcSEcCtD
Nefazodone—Dyspepsia—Valproic Acid—migraine	4.53e-05	0.000579	CcSEcCtD
Nefazodone—Convulsion—Gabapentin—migraine	4.53e-05	0.000578	CcSEcCtD
Nefazodone—ABCB1—head—migraine	4.52e-05	0.00211	CbGeAlD
Nefazodone—Hypertension—Gabapentin—migraine	4.51e-05	0.000576	CcSEcCtD
Nefazodone—Shock—Timolol—migraine	4.51e-05	0.000576	CcSEcCtD
Nefazodone—Decreased appetite—Valproic Acid—migraine	4.47e-05	0.000571	CcSEcCtD
Nefazodone—Alopecia—Topiramate—migraine	4.46e-05	0.00057	CcSEcCtD
Nefazodone—Chest pain—Gabapentin—migraine	4.45e-05	0.000568	CcSEcCtD
Nefazodone—Arthralgia—Gabapentin—migraine	4.45e-05	0.000568	CcSEcCtD
Nefazodone—Myalgia—Gabapentin—migraine	4.45e-05	0.000568	CcSEcCtD
Nefazodone—Anxiety—Gabapentin—migraine	4.43e-05	0.000566	CcSEcCtD
Nefazodone—Hyperhidrosis—Timolol—migraine	4.43e-05	0.000566	CcSEcCtD
Nefazodone—Pain—Valproic Acid—migraine	4.4e-05	0.000562	CcSEcCtD
Nefazodone—Constipation—Valproic Acid—migraine	4.4e-05	0.000562	CcSEcCtD
Nefazodone—Discomfort—Gabapentin—migraine	4.4e-05	0.000562	CcSEcCtD
Nefazodone—Anorexia—Timolol—migraine	4.37e-05	0.000558	CcSEcCtD
Nefazodone—Dry mouth—Gabapentin—migraine	4.35e-05	0.000556	CcSEcCtD
Nefazodone—Flatulence—Topiramate—migraine	4.33e-05	0.000553	CcSEcCtD
Nefazodone—Nausea—Verapamil—migraine	4.31e-05	0.000551	CcSEcCtD
Nefazodone—Dysgeusia—Topiramate—migraine	4.31e-05	0.00055	CcSEcCtD
Nefazodone—Confusional state—Gabapentin—migraine	4.3e-05	0.000549	CcSEcCtD
Nefazodone—ABCB1—nervous system—migraine	4.29e-05	0.002	CbGeAlD
Nefazodone—Hypotension—Timolol—migraine	4.28e-05	0.000547	CcSEcCtD
Nefazodone—Oedema—Gabapentin—migraine	4.26e-05	0.000545	CcSEcCtD
Nefazodone—Anaphylactic shock—Gabapentin—migraine	4.26e-05	0.000545	CcSEcCtD
Nefazodone—Back pain—Topiramate—migraine	4.25e-05	0.000543	CcSEcCtD
Nefazodone—Feeling abnormal—Valproic Acid—migraine	4.24e-05	0.000542	CcSEcCtD
Nefazodone—Infection—Gabapentin—migraine	4.24e-05	0.000541	CcSEcCtD
Nefazodone—Muscle spasms—Topiramate—migraine	4.23e-05	0.00054	CcSEcCtD
Nefazodone—Gastrointestinal pain—Valproic Acid—migraine	4.21e-05	0.000537	CcSEcCtD
Nefazodone—Fluphenazine—HTR2A—migraine	4.2e-05	0.0157	CrCbGaD
Nefazodone—Shock—Gabapentin—migraine	4.2e-05	0.000536	CcSEcCtD
Nefazodone—Thrombocytopenia—Gabapentin—migraine	4.18e-05	0.000533	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Timolol—migraine	4.17e-05	0.000533	CcSEcCtD
Nefazodone—Tachycardia—Gabapentin—migraine	4.16e-05	0.000532	CcSEcCtD
Nefazodone—Vision blurred—Topiramate—migraine	4.14e-05	0.000529	CcSEcCtD
Nefazodone—Insomnia—Timolol—migraine	4.14e-05	0.000529	CcSEcCtD
Nefazodone—ABCB1—central nervous system—migraine	4.13e-05	0.00193	CbGeAlD
Nefazodone—Hyperhidrosis—Gabapentin—migraine	4.12e-05	0.000527	CcSEcCtD
Nefazodone—Tremor—Topiramate—migraine	4.12e-05	0.000526	CcSEcCtD
Nefazodone—Paraesthesia—Timolol—migraine	4.11e-05	0.000525	CcSEcCtD
Nefazodone—Urticaria—Valproic Acid—migraine	4.09e-05	0.000522	CcSEcCtD
Nefazodone—Dyspnoea—Timolol—migraine	4.08e-05	0.000522	CcSEcCtD
Nefazodone—Ill-defined disorder—Topiramate—migraine	4.08e-05	0.000521	CcSEcCtD
Nefazodone—Somnolence—Timolol—migraine	4.07e-05	0.00052	CcSEcCtD
Nefazodone—Abdominal pain—Valproic Acid—migraine	4.07e-05	0.00052	CcSEcCtD
Nefazodone—Body temperature increased—Valproic Acid—migraine	4.07e-05	0.00052	CcSEcCtD
Nefazodone—Anorexia—Gabapentin—migraine	4.07e-05	0.000519	CcSEcCtD
Nefazodone—Anaemia—Topiramate—migraine	4.06e-05	0.000519	CcSEcCtD
Nefazodone—Agitation—Topiramate—migraine	4.04e-05	0.000516	CcSEcCtD
Nefazodone—ABCB1—cerebellum—migraine	4.03e-05	0.00188	CbGeAlD
Nefazodone—Dyspepsia—Timolol—migraine	4.03e-05	0.000515	CcSEcCtD
Nefazodone—Hypotension—Gabapentin—migraine	3.99e-05	0.000509	CcSEcCtD
Nefazodone—Decreased appetite—Timolol—migraine	3.98e-05	0.000509	CcSEcCtD
Nefazodone—Malaise—Topiramate—migraine	3.96e-05	0.000507	CcSEcCtD
Nefazodone—Vertigo—Topiramate—migraine	3.95e-05	0.000505	CcSEcCtD
Nefazodone—Syncope—Topiramate—migraine	3.94e-05	0.000504	CcSEcCtD
Nefazodone—Leukopenia—Topiramate—migraine	3.94e-05	0.000503	CcSEcCtD
Nefazodone—Pain—Timolol—migraine	3.92e-05	0.0005	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Gabapentin—migraine	3.89e-05	0.000496	CcSEcCtD
Nefazodone—Palpitations—Topiramate—migraine	3.89e-05	0.000496	CcSEcCtD
Nefazodone—Loss of consciousness—Topiramate—migraine	3.86e-05	0.000494	CcSEcCtD
Nefazodone—Insomnia—Gabapentin—migraine	3.86e-05	0.000493	CcSEcCtD
Nefazodone—Cough—Topiramate—migraine	3.84e-05	0.00049	CcSEcCtD
Nefazodone—Paraesthesia—Gabapentin—migraine	3.83e-05	0.000489	CcSEcCtD
Nefazodone—Convulsion—Topiramate—migraine	3.81e-05	0.000487	CcSEcCtD
Nefazodone—Dyspnoea—Gabapentin—migraine	3.8e-05	0.000486	CcSEcCtD
Nefazodone—Hypertension—Topiramate—migraine	3.8e-05	0.000485	CcSEcCtD
Nefazodone—Somnolence—Gabapentin—migraine	3.79e-05	0.000484	CcSEcCtD
Nefazodone—Hypersensitivity—Valproic Acid—migraine	3.79e-05	0.000484	CcSEcCtD
Nefazodone—Feeling abnormal—Timolol—migraine	3.77e-05	0.000482	CcSEcCtD
Nefazodone—Dyspepsia—Gabapentin—migraine	3.75e-05	0.00048	CcSEcCtD
Nefazodone—Gastrointestinal pain—Timolol—migraine	3.74e-05	0.000478	CcSEcCtD
Nefazodone—Myalgia—Topiramate—migraine	3.74e-05	0.000478	CcSEcCtD
Nefazodone—Chest pain—Topiramate—migraine	3.74e-05	0.000478	CcSEcCtD
Nefazodone—Arthralgia—Topiramate—migraine	3.74e-05	0.000478	CcSEcCtD
Nefazodone—Anxiety—Topiramate—migraine	3.73e-05	0.000477	CcSEcCtD
Nefazodone—Decreased appetite—Gabapentin—migraine	3.71e-05	0.000474	CcSEcCtD
Nefazodone—Discomfort—Topiramate—migraine	3.7e-05	0.000472	CcSEcCtD
Nefazodone—Asthenia—Valproic Acid—migraine	3.69e-05	0.000472	CcSEcCtD
Nefazodone—Dry mouth—Topiramate—migraine	3.66e-05	0.000468	CcSEcCtD
Nefazodone—Pain—Gabapentin—migraine	3.65e-05	0.000466	CcSEcCtD
Nefazodone—Constipation—Gabapentin—migraine	3.65e-05	0.000466	CcSEcCtD
Nefazodone—Pruritus—Valproic Acid—migraine	3.64e-05	0.000465	CcSEcCtD
Nefazodone—Urticaria—Timolol—migraine	3.64e-05	0.000465	CcSEcCtD
Nefazodone—Abdominal pain—Timolol—migraine	3.62e-05	0.000463	CcSEcCtD
Nefazodone—Body temperature increased—Timolol—migraine	3.62e-05	0.000463	CcSEcCtD
Nefazodone—Confusional state—Topiramate—migraine	3.62e-05	0.000462	CcSEcCtD
Nefazodone—Oedema—Topiramate—migraine	3.59e-05	0.000458	CcSEcCtD
Nefazodone—Infection—Topiramate—migraine	3.56e-05	0.000455	CcSEcCtD
Nefazodone—Shock—Topiramate—migraine	3.53e-05	0.000451	CcSEcCtD
Nefazodone—Diarrhoea—Valproic Acid—migraine	3.52e-05	0.00045	CcSEcCtD
Nefazodone—Feeling abnormal—Gabapentin—migraine	3.51e-05	0.000449	CcSEcCtD
Nefazodone—Thrombocytopenia—Topiramate—migraine	3.51e-05	0.000449	CcSEcCtD
Nefazodone—Tachycardia—Topiramate—migraine	3.5e-05	0.000447	CcSEcCtD
Nefazodone—Gastrointestinal pain—Gabapentin—migraine	3.49e-05	0.000446	CcSEcCtD
Nefazodone—Hyperhidrosis—Topiramate—migraine	3.47e-05	0.000443	CcSEcCtD
Nefazodone—Anorexia—Topiramate—migraine	3.42e-05	0.000437	CcSEcCtD
Nefazodone—Dizziness—Valproic Acid—migraine	3.4e-05	0.000435	CcSEcCtD
Nefazodone—Urticaria—Gabapentin—migraine	3.39e-05	0.000433	CcSEcCtD
Nefazodone—Hypersensitivity—Timolol—migraine	3.37e-05	0.000431	CcSEcCtD
Nefazodone—Abdominal pain—Gabapentin—migraine	3.37e-05	0.000431	CcSEcCtD
Nefazodone—Body temperature increased—Gabapentin—migraine	3.37e-05	0.000431	CcSEcCtD
Nefazodone—Trifluoperazine—HTR2A—migraine	3.36e-05	0.0125	CrCbGaD
Nefazodone—Hypotension—Topiramate—migraine	3.35e-05	0.000428	CcSEcCtD
Nefazodone—Perphenazine—HTR2A—migraine	3.32e-05	0.0124	CrCbGaD
Nefazodone—Asthenia—Timolol—migraine	3.29e-05	0.00042	CcSEcCtD
Nefazodone—ABCB1—brain—migraine	3.28e-05	0.00153	CbGeAlD
Nefazodone—Vomiting—Valproic Acid—migraine	3.27e-05	0.000418	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Topiramate—migraine	3.27e-05	0.000418	CcSEcCtD
Nefazodone—Quetiapine—HTR2A—migraine	3.26e-05	0.0122	CrCbGaD
Nefazodone—Insomnia—Topiramate—migraine	3.25e-05	0.000415	CcSEcCtD
Nefazodone—Rash—Valproic Acid—migraine	3.24e-05	0.000414	CcSEcCtD
Nefazodone—Dermatitis—Valproic Acid—migraine	3.24e-05	0.000414	CcSEcCtD
Nefazodone—Pruritus—Timolol—migraine	3.24e-05	0.000414	CcSEcCtD
Nefazodone—Headache—Valproic Acid—migraine	3.22e-05	0.000412	CcSEcCtD
Nefazodone—Paraesthesia—Topiramate—migraine	3.22e-05	0.000412	CcSEcCtD
Nefazodone—Dyspnoea—Topiramate—migraine	3.2e-05	0.000409	CcSEcCtD
Nefazodone—Somnolence—Topiramate—migraine	3.19e-05	0.000408	CcSEcCtD
Nefazodone—Dyspepsia—Topiramate—migraine	3.16e-05	0.000404	CcSEcCtD
Nefazodone—Hypersensitivity—Gabapentin—migraine	3.14e-05	0.000401	CcSEcCtD
Nefazodone—Diarrhoea—Timolol—migraine	3.13e-05	0.0004	CcSEcCtD
Nefazodone—Decreased appetite—Topiramate—migraine	3.12e-05	0.000398	CcSEcCtD
Nefazodone—Pain—Topiramate—migraine	3.07e-05	0.000392	CcSEcCtD
Nefazodone—Constipation—Topiramate—migraine	3.07e-05	0.000392	CcSEcCtD
Nefazodone—Asthenia—Gabapentin—migraine	3.06e-05	0.000391	CcSEcCtD
Nefazodone—Nausea—Valproic Acid—migraine	3.06e-05	0.00039	CcSEcCtD
Nefazodone—Dizziness—Timolol—migraine	3.03e-05	0.000387	CcSEcCtD
Nefazodone—Pruritus—Gabapentin—migraine	3.02e-05	0.000385	CcSEcCtD
Nefazodone—Feeling abnormal—Topiramate—migraine	2.96e-05	0.000378	CcSEcCtD
Nefazodone—Gastrointestinal pain—Topiramate—migraine	2.93e-05	0.000375	CcSEcCtD
Nefazodone—Diarrhoea—Gabapentin—migraine	2.92e-05	0.000373	CcSEcCtD
Nefazodone—Vomiting—Timolol—migraine	2.91e-05	0.000372	CcSEcCtD
Nefazodone—Rash—Timolol—migraine	2.89e-05	0.000369	CcSEcCtD
Nefazodone—Dermatitis—Timolol—migraine	2.88e-05	0.000369	CcSEcCtD
Nefazodone—Headache—Timolol—migraine	2.87e-05	0.000367	CcSEcCtD
Nefazodone—Urticaria—Topiramate—migraine	2.85e-05	0.000364	CcSEcCtD
Nefazodone—Abdominal pain—Topiramate—migraine	2.84e-05	0.000362	CcSEcCtD
Nefazodone—Body temperature increased—Topiramate—migraine	2.84e-05	0.000362	CcSEcCtD
Nefazodone—Dizziness—Gabapentin—migraine	2.82e-05	0.00036	CcSEcCtD
Nefazodone—Nausea—Timolol—migraine	2.72e-05	0.000348	CcSEcCtD
Nefazodone—Vomiting—Gabapentin—migraine	2.71e-05	0.000346	CcSEcCtD
Nefazodone—Rash—Gabapentin—migraine	2.69e-05	0.000344	CcSEcCtD
Nefazodone—Dermatitis—Gabapentin—migraine	2.69e-05	0.000343	CcSEcCtD
Nefazodone—Headache—Gabapentin—migraine	2.67e-05	0.000341	CcSEcCtD
Nefazodone—Hypersensitivity—Topiramate—migraine	2.64e-05	0.000338	CcSEcCtD
Nefazodone—Asthenia—Topiramate—migraine	2.57e-05	0.000329	CcSEcCtD
Nefazodone—Pruritus—Topiramate—migraine	2.54e-05	0.000324	CcSEcCtD
Nefazodone—Nausea—Gabapentin—migraine	2.53e-05	0.000324	CcSEcCtD
Nefazodone—Diarrhoea—Topiramate—migraine	2.45e-05	0.000314	CcSEcCtD
Nefazodone—Dizziness—Topiramate—migraine	2.37e-05	0.000303	CcSEcCtD
Nefazodone—Vomiting—Topiramate—migraine	2.28e-05	0.000291	CcSEcCtD
Nefazodone—Rash—Topiramate—migraine	2.26e-05	0.000289	CcSEcCtD
Nefazodone—Dermatitis—Topiramate—migraine	2.26e-05	0.000289	CcSEcCtD
Nefazodone—Headache—Topiramate—migraine	2.25e-05	0.000287	CcSEcCtD
Nefazodone—Nausea—Topiramate—migraine	2.13e-05	0.000272	CcSEcCtD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	1.7e-05	0.000443	CbGpPWpGaD
Nefazodone—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	1.7e-05	0.000442	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR ligand binding—EDNRA—migraine	1.69e-05	0.00044	CbGpPWpGaD
Nefazodone—HTR2A—GPCR ligand binding—HTR7—migraine	1.67e-05	0.000436	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR ligand binding—HTR7—migraine	1.64e-05	0.000427	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CALCRL—migraine	1.64e-05	0.000426	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—RAMP1—migraine	1.64e-05	0.000426	CbGpPWpGaD
Nefazodone—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	1.63e-05	0.000425	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CALCRL—migraine	1.63e-05	0.000424	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—RAMP1—migraine	1.63e-05	0.000424	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR ligand binding—CALCA—migraine	1.63e-05	0.000424	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—HTR2B—migraine	1.62e-05	0.000422	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—HTR2B—migraine	1.62e-05	0.000421	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—HTR2B—migraine	1.58e-05	0.000412	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—HTR1D—migraine	1.58e-05	0.000412	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—RAMP1—migraine	1.56e-05	0.000406	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CALCRL—migraine	1.56e-05	0.000406	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR ligand binding—HTR7—migraine	1.52e-05	0.000396	CbGpPWpGaD
Nefazodone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	1.51e-05	0.000392	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—CACNA1A—migraine	1.48e-05	0.000385	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—HTR2B—migraine	1.47e-05	0.000383	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—RAMP1—migraine	1.42e-05	0.000368	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CALCRL—migraine	1.42e-05	0.000368	CbGpPWpGaD
Nefazodone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	1.4e-05	0.000364	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CALCRL—migraine	1.39e-05	0.000361	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—RAMP1—migraine	1.39e-05	0.000361	CbGpPWpGaD
Nefazodone—HTR1A—GPCR ligand binding—HTR2A—migraine	1.36e-05	0.000353	CbGpPWpGaD
Nefazodone—HTR2C—GPCR ligand binding—HTR2A—migraine	1.35e-05	0.000351	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—HTR1B—migraine	1.34e-05	0.00035	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—HTR1B—migraine	1.34e-05	0.000348	CbGpPWpGaD
Nefazodone—HTR1A—SIDS Susceptibility Pathways—TNF—migraine	1.34e-05	0.000348	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR ligand binding—HTR2A—migraine	1.29e-05	0.000336	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—RAMP1—migraine	1.29e-05	0.000335	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CALCRL—migraine	1.29e-05	0.000335	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—HTR1A—migraine	1.29e-05	0.000335	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—HTR1B—migraine	1.28e-05	0.000333	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	1.28e-05	0.000332	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—NPS—migraine	1.27e-05	0.000332	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—TAC1—migraine	1.27e-05	0.000332	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—TAC1—migraine	1.27e-05	0.00033	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—NPS—migraine	1.27e-05	0.00033	CbGpPWpGaD
Nefazodone—ABCB1—Allograft Rejection—TNF—migraine	1.25e-05	0.000326	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—HTR2C—migraine	1.25e-05	0.000325	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—HTR1A—migraine	1.23e-05	0.000321	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—HTR1B—migraine	1.22e-05	0.000318	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—EDNRA—migraine	1.22e-05	0.000316	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—HTR1B—migraine	1.21e-05	0.000316	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—NPS—migraine	1.21e-05	0.000316	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—TAC1—migraine	1.21e-05	0.000316	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—EDNRA—migraine	1.21e-05	0.000315	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HTR1D—migraine	1.19e-05	0.00031	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—HTR2C—migraine	1.19e-05	0.00031	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HTR1D—migraine	1.18e-05	0.000308	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—CALCA—migraine	1.17e-05	0.000305	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—HTR1A—migraine	1.17e-05	0.000304	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—CACNA1A—migraine	1.17e-05	0.000304	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—CALCA—migraine	1.16e-05	0.000303	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—HTR1B—migraine	1.16e-05	0.000303	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—HTR1B—migraine	1.16e-05	0.000302	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—EDNRA—migraine	1.16e-05	0.000301	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—TAC1—migraine	1.16e-05	0.000301	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—NPS—migraine	1.16e-05	0.000301	CbGpPWpGaD
Nefazodone—HTR2A—SIDS Susceptibility Pathways—TNF—migraine	1.16e-05	0.000301	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—TAC1—migraine	1.15e-05	0.0003	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—NPS—migraine	1.15e-05	0.0003	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR ligand binding—HTR2A—migraine	1.15e-05	0.000299	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—HTR1B—migraine	1.14e-05	0.000296	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—HTR2C—migraine	1.13e-05	0.000295	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HTR1D—migraine	1.13e-05	0.000295	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—HTR1A—migraine	1.12e-05	0.000291	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—HTR1A—migraine	1.12e-05	0.000291	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—CALCA—migraine	1.11e-05	0.00029	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HTR2B—migraine	1.11e-05	0.000288	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—EDNRA—migraine	1.1e-05	0.000287	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—TAC1—migraine	1.1e-05	0.000287	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—NPS—migraine	1.1e-05	0.000287	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—NPS—migraine	1.1e-05	0.000287	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—TAC1—migraine	1.1e-05	0.000287	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HTR2B—migraine	1.1e-05	0.000287	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—EDNRA—migraine	1.1e-05	0.000286	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—HTR1A—migraine	1.09e-05	0.000285	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—HTR7—migraine	1.09e-05	0.000285	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—HTR7—migraine	1.09e-05	0.000283	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—HTR2C—migraine	1.08e-05	0.000281	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—HTR2C—migraine	1.08e-05	0.000281	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—TAC1—migraine	1.08e-05	0.000281	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—NPS—migraine	1.08e-05	0.000281	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—CACNA1A—migraine	1.07e-05	0.000278	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR ligand binding—HTR2A—migraine	1.07e-05	0.000278	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—CALCA—migraine	1.06e-05	0.000277	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—CALCA—migraine	1.06e-05	0.000275	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—HTR2C—migraine	1.06e-05	0.000275	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—HTR1B—migraine	1.06e-05	0.000275	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—HTR1B—migraine	1.05e-05	0.000275	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HTR2B—migraine	1.05e-05	0.000274	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—EDNRA—migraine	1.05e-05	0.000274	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—EDNRA—migraine	1.05e-05	0.000273	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—HTR7—migraine	1.04e-05	0.000271	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—HTR1B—migraine	1.03e-05	0.000269	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—EDNRA—migraine	1.03e-05	0.000268	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—HTR1D—migraine	1.03e-05	0.000268	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—HTR1A—migraine	1.02e-05	0.000265	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—HTR1A—migraine	1.02e-05	0.000264	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—CALCA—migraine	1.01e-05	0.000263	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—CALCA—migraine	1.01e-05	0.000263	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HTR1D—migraine	1.01e-05	0.000262	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—NPS—migraine	1e-05	0.000261	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—TAC1—migraine	1e-05	0.000261	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—TAC1—migraine	1e-05	0.00026	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—NPS—migraine	1e-05	0.00026	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—HTR1A—migraine	9.94e-06	0.000259	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—HTR7—migraine	9.94e-06	0.000259	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—CALCA—migraine	9.9e-06	0.000258	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—HTR7—migraine	9.89e-06	0.000257	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—HTR2C—migraine	9.82e-06	0.000256	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—HTR2C—migraine	9.8e-06	0.000255	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—NPS—migraine	9.79e-06	0.000255	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—TAC1—migraine	9.79e-06	0.000255	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—LRP1—migraine	9.74e-06	0.000254	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—LRP1—migraine	9.69e-06	0.000252	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—HTR2C—migraine	9.6e-06	0.00025	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—HTR1B—migraine	9.59e-06	0.00025	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—HTR2B—migraine	9.56e-06	0.000249	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—EDNRA—migraine	9.55e-06	0.000249	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—EDNRA—migraine	9.54e-06	0.000248	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—HTR7—migraine	9.47e-06	0.000246	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—HTR7—migraine	9.46e-06	0.000246	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HTR2B—migraine	9.36e-06	0.000244	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HTR1D—migraine	9.35e-06	0.000244	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—EDNRA—migraine	9.34e-06	0.000243	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—LRP1—migraine	9.28e-06	0.000242	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—HTR7—migraine	9.26e-06	0.000241	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—HTR1A—migraine	9.23e-06	0.00024	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—CALCA—migraine	9.2e-06	0.000239	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—CALCA—migraine	9.18e-06	0.000239	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—TAC1—migraine	9.09e-06	0.000237	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—NPS—migraine	9.09e-06	0.000237	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—CALCA—migraine	8.99e-06	0.000234	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—HTR2C—migraine	8.92e-06	0.000232	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HTR2B—migraine	8.7e-06	0.000226	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—EDNRA—migraine	8.68e-06	0.000226	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—HTR7—migraine	8.6e-06	0.000224	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—HTR7—migraine	8.59e-06	0.000224	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—LRP1—migraine	8.42e-06	0.000219	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—HTR7—migraine	8.41e-06	0.000219	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CALCA—migraine	8.35e-06	0.000217	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—LRP1—migraine	8.24e-06	0.000215	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CACNA1A—migraine	8.07e-06	0.00021	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—HTR7—migraine	7.81e-06	0.000203	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—HTR2A—migraine	7.67e-06	0.0002	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—LRP1—migraine	7.66e-06	0.000199	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—HTR2A—migraine	7.63e-06	0.000199	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CACNA1A—migraine	7.6e-06	0.000198	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NOTCH4—migraine	7.47e-06	0.000195	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NOTCH4—migraine	7.44e-06	0.000194	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—HTR2A—migraine	7.3e-06	0.00019	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HTR1B—migraine	7.21e-06	0.000188	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HTR1B—migraine	7.17e-06	0.000187	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NOTCH4—migraine	7.12e-06	0.000185	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—HTR2A—migraine	6.96e-06	0.000181	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—HTR2A—migraine	6.93e-06	0.00018	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HTR1A—migraine	6.91e-06	0.00018	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HTR1B—migraine	6.87e-06	0.000179	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NPS—migraine	6.84e-06	0.000178	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PGR—migraine	6.84e-06	0.000178	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TAC1—migraine	6.84e-06	0.000178	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NPS—migraine	6.8e-06	0.000177	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TAC1—migraine	6.8e-06	0.000177	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PGR—migraine	6.8e-06	0.000177	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HTR2C—migraine	6.7e-06	0.000175	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—HTR2A—migraine	6.63e-06	0.000173	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HTR1A—migraine	6.61e-06	0.000172	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—EDNRA—migraine	6.52e-06	0.00017	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TAC1—migraine	6.51e-06	0.000169	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NPS—migraine	6.51e-06	0.000169	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PGR—migraine	6.51e-06	0.000169	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—EDNRA—migraine	6.49e-06	0.000169	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—HTR2A—migraine	6.48e-06	0.000169	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NOTCH4—migraine	6.46e-06	0.000168	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HTR2C—migraine	6.38e-06	0.000166	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NOTCH3—migraine	6.35e-06	0.000165	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NOTCH3—migraine	6.32e-06	0.000165	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NOTCH4—migraine	6.32e-06	0.000165	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CALCA—migraine	6.28e-06	0.000163	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CALCA—migraine	6.24e-06	0.000163	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—HTR1B—migraine	6.23e-06	0.000162	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—EDNRA—migraine	6.21e-06	0.000162	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	6.18e-06	0.000161	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HTR1B—migraine	6.1e-06	0.000159	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NOTCH3—migraine	6.05e-06	0.000158	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—HTR2A—migraine	6.02e-06	0.000157	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—HTR1A—migraine	6e-06	0.000156	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CALCA—migraine	5.98e-06	0.000156	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TAC1—migraine	5.91e-06	0.000154	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NPS—migraine	5.91e-06	0.000154	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PGR—migraine	5.91e-06	0.000154	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—HTR2A—migraine	5.89e-06	0.000153	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NOTCH4—migraine	5.87e-06	0.000153	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HTR1A—migraine	5.87e-06	0.000153	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HTR7—migraine	5.87e-06	0.000153	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HTR7—migraine	5.84e-06	0.000152	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—HTR2C—migraine	5.79e-06	0.000151	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NPS—migraine	5.78e-06	0.000151	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TAC1—migraine	5.78e-06	0.000151	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PGR—migraine	5.78e-06	0.000151	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HTR2C—migraine	5.67e-06	0.000148	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HTR1B—migraine	5.67e-06	0.000148	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—EDNRA—migraine	5.63e-06	0.000147	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HTR7—migraine	5.59e-06	0.000146	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—EDNRA—migraine	5.52e-06	0.000144	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NOTCH3—migraine	5.49e-06	0.000143	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—HTR2A—migraine	5.47e-06	0.000142	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HTR1A—migraine	5.46e-06	0.000142	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CALCA—migraine	5.42e-06	0.000141	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NOTCH3—migraine	5.38e-06	0.00014	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TAC1—migraine	5.37e-06	0.00014	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PGR—migraine	5.37e-06	0.00014	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NPS—migraine	5.37e-06	0.00014	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CALCA—migraine	5.31e-06	0.000138	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HTR2C—migraine	5.27e-06	0.000137	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—EDNRA—migraine	5.13e-06	0.000133	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—HTR7—migraine	5.07e-06	0.000132	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TGFBR2—migraine	5.06e-06	0.000132	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TGFBR2—migraine	5.03e-06	0.000131	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NOTCH3—migraine	4.99e-06	0.00013	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CACNA1A—migraine	4.97e-06	0.000129	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HTR7—migraine	4.97e-06	0.000129	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CALCA—migraine	4.93e-06	0.000128	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—MTHFR—migraine	4.89e-06	0.000127	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TGFBR2—migraine	4.82e-06	0.000125	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HTR7—migraine	4.61e-06	0.00012	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TGFBR2—migraine	4.37e-06	0.000114	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TGFBR2—migraine	4.28e-06	0.000111	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HTR2A—migraine	4.11e-06	0.000107	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HTR2A—migraine	4.09e-06	0.000107	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TGFBR2—migraine	3.97e-06	0.000103	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HTR2A—migraine	3.92e-06	0.000102	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—MTHFR—migraine	3.86e-06	0.0001	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—ESR1—migraine	3.65e-06	9.5e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—ESR1—migraine	3.63e-06	9.45e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—MTHFR—migraine	3.54e-06	9.21e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HTR2A—migraine	3.48e-06	9.06e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—ESR1—migraine	3.48e-06	9.05e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HTR2A—migraine	3.23e-06	8.41e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—ESR1—migraine	3.15e-06	8.21e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—ESR1—migraine	3.09e-06	8.04e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—ESR1—migraine	2.87e-06	7.47e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—MTHFR—migraine	2.67e-06	6.95e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—MTHFR—migraine	2.52e-06	6.55e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—MTHFR—migraine	1.64e-06	4.28e-05	CbGpPWpGaD
